The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Arena Pharmaceuticals, Inc(NASDAQ:ARNA)

Arena Pharmaceuticals, Inc., a biopharmaceutical company, focuses on providing novel medicines with pharmacology and pharmacokinetics to patients worldwide. Its investigational clinical programs include Etrasimod (APD334) that is in Phase III clinical trial for ulcerative colitis, Phase IIb/III clin...
Website: http://www.arenapharm.com
Founded: 1997
Full Time Employees: 363 (May 2021)
Sector: Healthcare
Industry: Biotechnology
Arena Pharmaceuticals Op Cashflow Per Share ttm
Arena Pharmaceuticals Free Cashflow Per Share ttm
Arena Pharmaceuticals Cash Per Share ttm
Arena Pharmaceuticals P/S ratio ttm
Arena Pharmaceuticals (GAAP) P/E ratio ttm
Arena Pharmaceuticals P/B ratio ttm
No extra charts and metrics for this ticker.